Breast Neoplasms: all 12,820 studies
Page 90 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With ChemotherapyStatus unknownNCT02771756Not applicable
- Low Dose Tomosynthesis Compared to Traditional TomosynthesisTerminatedNCT02771444Not applicable
- The HeartSpare Plus 1B TrialCompletedNCT02771353Phase 2
- Feasibility Study of the Addition of a Personal Trainer to the Post-Treatment Regimen of Breast Cancer SurvivorsCompletedNCT02770781Not applicable
- Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRICompletedNCT02770586Not applicable
- Culturally Tailored Educational and Support Program to Increase Quality of Life Among Korean Breast Cancer SurvivorsCompletedNCT02770469Not applicable
- Extended Treatment in Metastatic Breast Cancer With EribulinCompletedNCT02769364
- Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast CancerStatus unknownNCT02769104Phase 3
- Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving ChemotherapyWithdrawnNCT02768714Phase 3
- Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast CancerStatus unknownNCT02768415Phase 2
- Cambridge Brain Mets Trial 1TerminatedNCT02768337Phase 1/2
- Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast CancerCompletedNCT02767661Phase 3
- Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast CancerStatus unknownNCT02766530Phase 4
- PERCIST Criteria for Response Evaluation With Solid TumorsStatus unknownNCT02765620
- Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer PatientsStatus unknownNCT02765373
- Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer SurvivorsCompletedNCT02763228Not applicable
- A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast CancerCompletedNCT02761616
- Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by SurgeryCompletedNCT02760030Phase 2
- Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MHWithdrawnNCT02759549Not applicable
- Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal WireCompletedNCT02759133Not applicable
- KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour ResponseCompletedNCT02757651Phase 1/2
- Expanded Access to ANG1005 for Individual PatientsNo longer availableNCT02755987
- Trial to Compare Radiation Fibrosis With Five Versus Three FractionsActive, not recruitingNCT02755896Phase 2
- A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast CancerActive, not recruitingNCT02755272Phase 2
- Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer TreatmentActive, not recruitingNCT02754752Phase 2
- Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 NegativeCompletedNCT02754011Phase 1
- Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted TherapyCompletedNCT02753686
- Estrogen Receptor-Positive Breast Cancer Patient-Derived XenograftsCompletedNCT02752893
- Reliability and Validity of Self-measured Arm Circumference in Women With Breast CancerCompletedNCT02752659Not applicable
- Evaluation Of Lymph Nodes After Neoadjuvant ChemotherapyWithdrawnNCT02752009Not applicable
- Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast CancerCompletedNCT02751710Not applicable
- Nano MRI on 7 Tesla in Rectal and Breast CancerStatus unknownNCT02751606Phase 3
- Breast Cancer WEight Loss Study (BWEL Study)Active, not recruitingNCT02750826Phase 3
- Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast CancerActive, not recruitingNCT02750358Phase 2
- Pink Warrior-Support Group Toolkit for Breast Cancer SurvivorsCompletedNCT02750241Not applicable
- Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer PatientsStatus unknownNCT02749019Phase 1
- Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer SurgeryWithdrawnNCT02748746Not applicable
- Pharmacist's Influence on Breast Cancer Patient Quality of LifeCompletedNCT02746666Not applicable
- Overall Survival and Disease-free Survival in Breast Cancer Patients Under COSStatus unknownNCT02745262
- Comparison of Healthy Diets on Breast Cancer MarkersCompletedNCT02744079Not applicable
- Monitoring Plasma Tumor DNA in Early-Stage Breast CancerCompletedNCT02743910
- 99mTc-3PRGD2 SPECT/CT in Breast Cancer PatientsCompletedNCT02742168Not applicable
- A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast CancerCompletedNCT02742051Phase 2
- Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast CancerCompletedNCT02740491
- A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)CompletedNCT02738970Phase 1
- Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase InhibitorActive, not recruitingNCT02738866Phase 2
- Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation PneumonitisCompletedNCT02735746
- Physiotherapy in Women With Peripheral Persistent Pain Following Breast Cancer TreatmentCompletedNCT02735668Not applicable
- Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast CancersTerminatedNCT02734615Phase 1
- PEGI to Improve Shared Decision-Making for Breast ReconstructionCompletedNCT02734121Not applicable
- Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in AlgeriaCompletedNCT02733601
- Palliative and Oncology Care Model in Breast CancerCompletedNCT02730858Not applicable
- A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced DiseaseTerminatedNCT02730091Phase 3
- Efficacy and Safety of Wuling San on Breast Cancer-related LymphedemaStatus unknownNCT02726477Not applicable
- Breast Cancer Lung Late EffectsCompletedNCT02725840
- Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSIWithdrawnNCT02725658Not applicable
- Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast CancerWithdrawnNCT02725541Phase 2
- PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)CompletedNCT02723877Phase 1/2
- 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone MetastasesCompletedNCT02721433Phase 4
- Pectoral Nerves Blocks for Chronic PainStatus unknownNCT02719795Early Phase 1
- Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast CancerCompletedNCT02718144Phase 1/2
- Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical TrialCompletedNCT02716467Not applicable
- A Multicenter Breast Cancer Biospecimen RegistryStatus unknownNCT02712645
- Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast CancerTerminatedNCT02712437Not applicable
- Experience of Arab American Women With Breast Cancer: In-depth InterviewsCompletedNCT02710058
- Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast CancerTerminatedNCT02708511Phase 1
- Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia TapingStatus unknownNCT02707835Not applicable
- A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast CancerCompletedNCT02707510Not applicable
- Imaging the Patterns of Breast Cancer Early MetastasesCompletedNCT02706964Not applicable
- Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable
- Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast CancerTerminatedNCT02704312Not applicable
- MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy TreatmentCompletedNCT02702830
- Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast CancersCompletedNCT02701348Not applicable
- 1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast CancerTerminatedNCT02700776
- Screening for Breast Cancer With Digital Breast TomosynthesisCompletedNCT02698202Not applicable
- FDHT PET and Bicalutamide in Metastatic Breast CancerCompletedNCT02697032Phase 2
- Cancer in Patients on Dapagliflozin and Other Antidiabetic TreatmentCompletedNCT02695121
- The PROMISE Study: Duavee in Women With DCISCompletedNCT02694809Phase 2
- Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer PatientsStatus unknownNCT02694224Phase 2
- Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced NeutropeniaCompletedNCT02692742Phase 2
- Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After OperationStatus unknownNCT02691624
- Acupuncture and Breast Cancer RehabilitationCompletedNCT02691208Not applicable
- Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast CancerStatus unknownNCT02690636Phase 3
- Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast CancerStatus unknownNCT02690480Phase 2
- NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast CancerStatus unknownNCT02689921Phase 2
- REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without TrastuzumabCompletedNCT02688998Not applicable
- Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer PatientsStatus unknownNCT02688725Not applicable
- Assessing Treatment Response in Breast Cancer With Functional ImagingCompletedNCT02688257
- Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast CancerCompletedNCT02687490Phase 2
- Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice NurseStatus unknownNCT02686918Not applicable
- Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast CancerStatus unknownNCT02685657Phase 2
- A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast CancerWithdrawnNCT02685306Phase 2
- Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)TerminatedNCT02685111Phase 2
- Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast CancerCompletedNCT02685059Phase 2
- A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast CancerCompletedNCT02684032Phase 1
- Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot StudyCompletedNCT02682836Not applicable
- Denosumab as an add-on Neoadjuvant Treatment (GeparX)CompletedNCT02682693Phase 2
- A Mail and Video-based Weight Loss Trial in Breast Cancer SurvivorsCompletedNCT02681965Not applicable
- uPAR PET/CT for Preoperative Staging of Breast Cancer PatientsCompletedNCT02681640Phase 2
- Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer PatientsStatus unknownNCT02681562Phase 2